{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:51:04Z","timestamp":1770479464715,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.diagmicrobio.2005.06.014","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T13:52:41Z","timestamp":1131025961000},"page":"311-317","source":"Crossref","is-referenced-by-count":8,"title":["Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains"],"prefix":"10.1016","volume":"53","author":[{"given":"Ronald N.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian A.","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L.H.","family":"Whittington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nebojsa","family":"Janjic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Pottumarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0732-8893(98)00114-X","article-title":"Antimicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolone-resistant strains","volume":"32","author":"Biedenbach","year":"1998","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib2","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/AAC.39.7.1606","article-title":"Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin","volume":"39","author":"Carlyn","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"RR-6","key":"10.1016\/j.diagmicrobio.2005.06.014_bib3","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib4","first-page":"1052","article-title":"Discontinuation of cefixime tablets\u2014United States","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib5","first-page":"1041","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae\u2014Hawaii and California, 2001","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib6","series-title":"Sexually transmitted disease surveillance 2003 supplement: Gonococcal Isolate Surveillance Project (GISP) annual report\u20142003","author":"Centers for Disease Control and Prevention","year":"2004"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib7","series-title":"Performance standards for antimicrobial susceptibility testing, 15th informational supplement M100-S15","author":"Clinical and Laboratory Standards Institute","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/35.4.535","article-title":"Evaluation of the in vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and \u03b2-lactamase\u2013producing bacteria","volume":"35","author":"Cormican","year":"1995","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/AAC.46.2.550-555.2002","article-title":"Activities of faropenem, an oral \u03b2-lactam, against recent US isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis","volume":"46","author":"Critchley","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000070616","article-title":"The art of fusion: from penams and cephems to penems","volume":"49","author":"Dalhoff","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000071141","article-title":"Target affinities of faropenem to and its impact on the morphology of Gram-positive and Gram-negative bacteria","volume":"49","author":"Dalhoff","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000072446","article-title":"\u03b2-lactamase stability of faropenem","volume":"49","author":"Dalhoff","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1128\/AAC.39.2.561","article-title":"DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae","volume":"39","author":"Deguchi","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1128\/AAC.40.4.1020","article-title":"Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles","volume":"40","author":"Deguchi","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0924-8579(01)00438-1","article-title":"Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methods","volume":"18","author":"Deshpande","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00007435-200406000-00007","article-title":"High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae","volume":"31","author":"Dewi","year":"2004","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib17","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1128\/AAC.39.7.1472","article-title":"Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testing","volume":"39","author":"Fuchs","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/42.4.553","article-title":"In-vitro activity of a novel penem, Men 10700, against meningococci and gonococci, and the effect of cysteine-containing supplement","volume":"42","author":"Hamilton-Miller","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib19","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1592\/phco.23.14.1497.31937","article-title":"Chemical and microbiological aspects of penems, a distinct class of \u03b2-lactams: focus on faropenem","volume":"23","author":"Hamilton-Miller","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib20","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.38.9.1974","article-title":"In vitro antibacterial activity and \u03b2-lactamase stability of SY5555, a new oral penem antibiotic","volume":"38","author":"Inoue","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib21","first-page":"437","article-title":"Remarkable increase in central Japan in 2001\u20132002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones","volume":"18","author":"Ito","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib22","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1128\/JCM.27.12.2758-2766.1989","article-title":"Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretative criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin and tetracycline","volume":"27","author":"Jones","year":"1989","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0732-8893(97)00042-4","article-title":"Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results","volume":"28","author":"Jones","year":"1997","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/45.suppl_3.67","article-title":"Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods","volume":"45","author":"Jones","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib25","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib26","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/bmj.324.7349.1324","article-title":"Are the trends in HIV, gonorrhea, and syphilis worsening in western Europe?","volume":"324","author":"Nicoll","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.45.3.734-738.2001","article-title":"Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC","volume":"45","author":"Shultz","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib28","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ijantimicag.2004.02.005","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993\u20132002: continuous increasing of ciprofloxacin-resistant isolates","volume":"24S","author":"Tanaka","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib29","series-title":"Antimicrobial resistance in Neisseria gonorrhoeae","author":"Tapsall","year":"2001"},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/39.1.35","article-title":"The in vitro activity of faropenem, a novel oral penem","volume":"39","author":"Woodcock","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.06.014_bib31","first-page":"488","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002","volume":"27","author":"World Health Organization Western Pacific Gonococcal Antimicrobial Surveillance Programme","year":"2003","journal-title":"Commun. Dis. Intell."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305001574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305001574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T17:06:10Z","timestamp":1586538370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889305001574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0732889305001574"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2005.06.014","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}